Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?

Virginie Siguret,Sebastian Voicu,Marie Neuwirth,Maxime Delrue, Etienne Gayat,Alain Stépanian,Bruno Mégarbane

Thrombosis Research（2020）

引用 0|浏览0

暂无评分

摘要

•The prevalence of aPL antibodies is poorly documented in ICU COVID-19 patients.•LA based on dRVVT system was positive in 85% of critically ill COVID-19 patients.•LA was not associated with thrombotic complications.•The prevalence of elevated anticardiolipin IgG/M/anti-beta2-GPI IgG was of 12%.

查看译文

关键词

COVID-19,Anticardiolipin,Anti-β2-glycoprotein-I,Lupus anticoagulant,Thrombosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要